This federal contract award, valued at $2,072.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of PEGASYS 180 MCG/ML VIALML, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award, valued at $3,598.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PEGASYS 180 MCG/ML VIALML, with a completion date of May 20, 2025. It is a firm-fixed-price delivery order contract, without any set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,072.25, is a Firm Fixed Price Delivery Order for the supply of PEGASYS 180 MCG/ML VIALML medical products. The contract has an ultimate completion date of April 8, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,072.25, is for the delivery of PEGASYS 180 MCG/ML VIALML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type. It has an ultimate completion date of March 26, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price type and a Ceiling Value of $2,763.00. The contract is not set aside and is for the provision of PEGASYS 180 MCG/ML VIALML, a pharmaceutical product. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,753.32 firm fixed-price delivery order is for the supply of PEGASYS 180 MCG/ML VIALML, a specialty medication. The contract has an ultimate completion date of December 10, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FA0J1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PEGASYS 180 MCG/ML VIALML, a medical product, with a total ceiling value of $1,381.50. It is a Firm Fixed Price delivery order contract with an ultimate completion date of January 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,072.25, is for the delivery of PEGASYS 180 MCG/ML VIALML, a pharmaceutical product. The contract is a Firm Fixed Price, Delivery Order type, with a period of performance through February 25, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) that...
The federal contract award is a Delivery Order valued at $12,023.01 issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PEGASYS 180 MCG/0.5 ML SYRINGE 0.5ML medical supplies. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a Delivery Order valued at $2,661.36 for the delivery of PEGASYS 180 MCG/ML VIALML, a pharmaceutical product, with a completion date of May 21, 2024. The contract is Firm Fixed Price and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...